Advertisement
  • Loading metrics

Human myiasis in Ecuador

  • Manuel Calvopina ,

    Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft

    manuel.calvopina@udla.edu.ec (MC); pcooper@sgul.ac.uk (PJC)

    Affiliation OneHealth Research Group, Facultad de Ciencias de la Salud, Universidad De Las Américas (UDLA), Quito, Ecuador

  • Esteban Ortiz-Prado,

    Roles Investigation, Writing – review & editing

    Affiliations OneHealth Research Group, Facultad de Ciencias de la Salud, Universidad De Las Américas (UDLA), Quito, Ecuador, Department of Cell Biology, Physiology and Immunology, Universitat de Barcelona, Barcelona, Spain

  • Byron Castañeda,

    Roles Investigation, Writing – review & editing

    Affiliation Institute of Tropical Medicine and International Health, Charité – Universitätsmedizin, Berlin, Germany

  • Isabel Cueva,

    Roles Investigation, Writing – review & editing

    Affiliation Instituto Superior Tecnológico, Cruz Roja Ecuatoriana, Quito, Ecuador

  • Richar Rodriguez-Hidalgo,

    Roles Investigation, Writing – review & editing

    Affiliations Instituto de Investigación en Salud Pública y Zoonosis - CIZ, Universidad Central del Ecuador, Quito, Ecuador, Facultad de Medicina Veterinaria y Zootecnia, Universidad Central del Ecuador, Quito, Ecuador

  • Philip J. Cooper

    Roles Formal analysis, Investigation, Writing – review & editing

    manuel.calvopina@udla.edu.ec (MC); pcooper@sgul.ac.uk (PJC)

    Affiliations Facultad de Ciencias Medicas, de la Salud y la Vida, Universidad Internacional del Ecuador, Quito, Ecuador, Institute of Infection and Immunity, St. George’s University of London, London, England

Human myiasis in Ecuador

  • Manuel Calvopina, 
  • Esteban Ortiz-Prado, 
  • Byron Castañeda, 
  • Isabel Cueva, 
  • Richar Rodriguez-Hidalgo, 
  • Philip J. Cooper
PLOS
x

Abstract

We review epidemiological and clinical data on human myiasis from Ecuador, based on data from the Ministry of Public Health (MPH) and a review of the available literature for clinical cases. The larvae of four flies, Dermatobia hominis, Cochliomyia hominivorax, Sarcophaga haemorrhoidalis, and Lucilia eximia, were identified as the causative agents in 39 reported clinical cases. The obligate D. hominis, causing furuncular lesions, caused 17 (43.5%) cases distributed along the tropical Pacific coast and the Amazon regions. The facultative C. hominivorax was identified in 15 (38%) clinical cases, infesting wound and cavitary lesions including orbital, nasal, aural and vaginal, and occurred in both subtropical and Andean regions. C. hominivorax was also identified in a nosocomial hospital-acquired wound. Single infestations were reported for S. haemorrhoidalis and L. eximia. Of the 39 clinical cases, 8 (21%) occurred in tourists. Ivermectin, when it became available, was used to treat furuncular, wound, and cavitary lesions successfully. MPH data for 2013–2015 registered 2,187 cases of which 54% were reported in men; 46% occurred in the tropical Pacific coast, 30% in the temperate Andes, 24% in the tropical Amazon, and 0.2% in the Galapagos Islands. The highest annual incidence was reported in the Amazon (23 cases/100,000 population), followed by Coast (5.1/100,000) and Andes (4.7/100,000). Human myiasis is a neglected and understudied ectoparasitic infestation, being endemic in both temperate and tropical regions of Ecuador. Improved education and awareness among populations living in, visitors to, and health personnel working in high-risk regions, is required for improved epidemiological surveillance, prevention, and correct diagnosis and treatment.

Author summary

Human myiasis is a neglected disease caused by ectoparasitic infestations of the skin, cavities and wounds by larvae of a wide variety of dipteran flies. Here, we review available data on human myiasis in Ecuador using a national registry of 2,187 cases and other information sources (39 clinical cases). We conclude that myiasis is endemic in both temperate and tropical regions of the country with greatest endemicity in the tropical lowlands of the Amazon (estimated annual incidence of 23 cases/100,000 population). Almost half clinical cases were cutaneous furuncular myiasis caused by Dermatobia hominis, which produced single lesions that were treated successfully with oral ivermectin followed by manual extraction. Also relatively common were infestations by Cochliomyia hominivorax, found in tropical and temperate regions in the Andean highlands, which infested wounds and cavities, occasionally involving hundreds of larvae and causing severe tissue damage when unrecognized. Our data shows that myiasis is a significant and unrecognized health problem in Ecuador, is likely to be significantly under-reported, and requires improved awareness among affected populations and improved education among health professionals for its diagnosis, treatment, and recognition of fly species.

Introduction

Human myiasis is an ectoparasitic infestation of living or dead tissues by larvae or maggots of several species of flies of the order Diptera, and together with the ectoparasitic scabies and tungiasis, is classed as a neglected tropical disease [1]. Human myiasis has a worldwide distribution but is more frequently reported from tropical regions, determined by the presence and geographic distribution of different fly species [2]. Ecuador is considered to be endemic for myiasis, particularly that caused by larvae of Dermatobia hominis that produce the furuncular clinical form [3].

Ecuador, located in the Western Pacific region of South America, lies on the Equator and is crossed by the Andes mountain range, thus dividing the country into distinct geoclimatic regions: western Pacific coastal with subtropical and tropical lowlands, central Andean with high mountains and deep valleys where climates may be temperate to subtropical, and eastern Amazon lowlands of humid tropical rain forest (Fig 1). In addition, the Galapagos Islands, 1,000 km off the mainland in the Pacific, are part of Ecuador [4]. Tropical and subtropical regions cover approximately 64% of Ecuador’s landmass of 276,841 km2. The total population of Ecuador in the 2010 census was 14,483,499 of which 53% live in the Pacific coastal, 42% in Andean, 5% in the Amazon region, and 0.2% in the Galapagos Islands [5].

thumbnail
Fig 1. Map of Ecuador.

Geographical distribution of the Ecuadorian Ministry of Public Health (MPH) registered cases per 100.000 inhabitants between 2013 and 2015. Data source RDACCA-Ecuadorian MPH. Figure made using ArcGIS software.

https://doi.org/10.1371/journal.pntd.0007858.g001

The dipterous larvae that cause myiasis include obligate (those feeding on live host tissue), facultative (decomposing tissues), and accidental (or pseudomyiasis) through ingestion of eggs or larvae from contaminated food or water. Myiasis may also be differentiated by the anatomical site of infestation: cutaneous (furuncular lesions and migratory or creeping dermal eruption); wound or traumatic causing cavitary lesions affecting the mouth (palate and periodontal), nose, nasopharynx, ear, eye (external and internal), anus and vagina; and enteric myiasis. Obligate myiasis can be serious or even fatal arising from complications relating to feeding of larvae on healthy tissues. Facultative myiasis may result in considerable pain and tissue damage while accidental myiasis is considered benign. Nosocomial myiasis refers to infestations that occur in a hospital setting [2,6].

Numerous fly species can cause human myiasis. The main species involved in obligate myiasis is D. hominis, which can be found from Mexico through Central and South America. Larvae feed under the skin, causing furuncular lesions with a typical air-pore. The main species causing facultative myiasis in the New World is Cochliomyia hominivorax (the New World screwworm). The Oestridae family of flies, a common cause of myiasis in sheep in Ecuador [7] have been associated with human infestations affecting eyes and nasopharyngeal cavities while accidental or pseudomyiasis has been associated with Syrphidae, Stratiomyidae, and Tephritidae families [8]. In Ecuador, four species of flies had been described to cause human myiasis: D. hominis, Oestrus ovis, C. hominivorax and Sarcophaga haemorrhoidalis [9].

Risk of myiasis is correlated with densities of fly populations and exposures through poor sanitation and personal hygiene, low socioeconomic status, and proximity to domestic animals. Elderly and seriously ill people, including those with severe intellectual disability and drug addiction are at higher risk. Neglected open wounds are also an important risk factor [10, 11]. Cutaneous myiasis is increasingly recognized among both tourist and business travelers to tropical regions of Central and South America [3].

There are limited data from Ecuador on the prevalence of human myiasis, geographic distribution, fly species involved, presence of different clinical forms, and management.

Methods

Ethics statement

The article is a review of published and publicly accessible anonymized material and required no human subjects ethics review.

We reviewed the published literature from local and international journals relating to human myiasis in Ecuador, as well as the official data from the National Automated Registry of Out-Patient Medical Consultations (RDACCA) database retrieved from the Ecuadorian Ministry of Public Health (MPH) repository. The main electronic libraries of PubMed, Scientific Electronic Library (Scielo), Latin American and Caribbean Health Sciences (LILACS), and Google Scholar were searched, using the following combination of terms in any given order,”myiasis and miasis”, “Dermatobia hominis”, “Oestrus ovis”, “Cochlyomyia hominivorax”, “Sarcophaga haemorrhoidalis”, “Ecuador”, with no restriction on language or publication date. Non-indexed local journals, bulletins, local meetings, abstracts, books, and clinical cases from personal collections and archives, were included in the review. RDACCA system uses International Classification of Diseases (ICD-10) to register cases. The information was retrieved searching for: B87 (Myiasis), B87.0 (Cutaneous myiasis), B87.1 (Wound myiasis), B87.2 (Ocular myiasis), B87.3 (Nasopharyngeal myiasis), B87.4 (Aural myiasis), B87.8 (Myiasis of other sites) and B87.9 (Myiasis, unspecified). All patients seen by the authors signed a consent form for publishing his/her case.

Results

Prevalence of infestation

National data were available for the three-year period, 2013 to 2015, during which 2,187 cases were registered by the MPH. We identified 39 clinical cases of human myiasis, 29 from the literature review [1336] and 10 (31%) from our own clinical experience. Eight (21%) cases were reported among travelers from USA, Spain, Japan, Israel, Argentina and Germany. Thirteen of the 39 (41%) clinical cases were reported in international journals, 7 (22%) in Ecuadorian journals, 2 (6%) in non-indexed local publications. (Table 1).

thumbnail
Table 1. Summary of clinical case reports of human myiasis originating in Ecuador.

https://doi.org/10.1371/journal.pntd.0007858.t001

Geographical distribution

Of the 2,187 cases registered by the Ecuadorian MPH between 2013 and 2015, 1,006 (46%) were from the Pacific coastal region, 651 (30%) from temperate regions of the Andes, 525 (24%) from the Amazon region, and 5 (0.2%) from the Galapagos Islands. Using population data from the 2010 census, these data allow us to estimate the annual incidence as being highest in the Amazon (23 cases/100,000 population), followed by Coastal (5.1/100,000) and Andean (4.7/100.000) regions (Fig 1). Of the 39 clinical cases (from non-MPH registry sources), 13 (33%) were infested in the mountainous temperate zone of the Andes, 14 (36%) in the Pacific coastal region, and 5 (13%) from the Amazon region. Of the 8 (21%) cases among travelers to Ecuador, the geographic origin of infestation was only specified in 1 case (Amazon region).

Age and sex

Among the MPH national official records (2013–2015) and the 39 clinical cases, myiasis was more frequent in men (54% and 64%, respectively). Among 2,187 registered cases by MPH, the proportion of cases was greatest among those of working age (i.e. 21–65 years) (Table 2). Among the 39 clinical cases, age ranged 4 months to 91 years (median, 30 years) with 51% occurring among those of working age (21–65 years), 26% in the elderly (i.e. >65 years), and 23% below 21 years of which 2 were infants (Table 1).

thumbnail
Table 2. Age group distribution for cases of myiasis reported in the Ecuadorian Ministry of Public Health registry (2013–2015) and for clinical cases identified from the literature search.

https://doi.org/10.1371/journal.pntd.0007858.t002

Biological classification

Almost half (49%) of clinical cases were obligatory and the other half (49%) were facultative. One case of accidental myiasis (or pseudomyiasis) was reported [35]. No biological status was identified among 2,187 registered cases from MPH. Data on biological classification (or fly species) were not available for the 2,187 MPH cases for which data were available only for clinical type (i.e. cutaneous, wound, etc.).

Clinical lesions and fly species involved

Of a total of 70 lesions observed in the 39 clinical cases, 29% of lesions were localized to the head region, and 30% affected limbs, 3% genital area, 29% thorax, and 9% abdomen (Table 1). Furuncular lesions were found in 17 (42.5%) of reported cases, all caused by D. hominis (Fig 2A and 2B). In 7 wound and 7 cavitary clinical lesions, C. hominivorax was identified as the fly involved (Fig 2C and 2D). In single individuals with wound or cavitary lesions, the causative agents were identified as Lucilia eximia and S. haemorrhoidalis, respectively. Larvae were not formally identified in two patients with wound lesions and in three with cavitary lesions [20, 21, 24, 32, 34]. Larvae in 4 patients with wound lesions were mistakenly identified as D. hominis but in fact were C. hominivorax [19, 29, 33]. One wound case after colostomy was considered nosocomial being acquired during hospitalization and the larvae identified as C. hominivorax [35]. Of six cases in which larval instar was described, the second larval instar occurred in four cases. No fly species was identified among 2,187 registered cases from MPH.

thumbnail
Fig 2. Furuncular and cavitary myiasis.

Furuncular myiasis in a 6-years-old boy from the Amazon region showing a clinical lesion with central air pore (A)—a single larva was identified as D. hominis 3rd instar (B). The child was treated with ivermectin (400 μg/kg once). After 48 h, a dead larva was extracted manually. More than 100 C. hominivorax 3rd instar larvae (C) manually extracted from the right eyeball (D) of a 91 year-old indigent indigenous Kichwa woman. Infestation occurred in the Andes region at 2,418 m, 80 km from Quito, the capital.

https://doi.org/10.1371/journal.pntd.0007858.g002

Greater than a thousand larvae were extracted from the 70 lesions observed in the 39 clinical cases, varying from single larvae of D. hominis in each cutaneous furuncular lesion to 15 larvae of L. eximia in a case of wound myiasis to >100 larvae of C. hominivorax in wound and cavitary myiasis. Some cases had multiple furuncular lesions of D. hominis: for example, a tourist from USA had 13 lesions (Table 1). Clinical type and site of myiasis of the 2187 registered cases from MPH were stratified by age group are shown in Table 3. The proportion of clinical forms of myiasis by age did change across age groups. The relative frequency of cutaneous myiasis was greater at the extremes of age while wound myiasis was less frequent compared to other forms in young children.

thumbnail
Table 3. Clinical type by age group reported between 2013 and 2015 in the Ecuadorian Ministry of Public Health registry by International Classification of Diseases codings (ICD-10).

https://doi.org/10.1371/journal.pntd.0007858.t003

Associated health conditions

Health conditions associated with clinical cases are detailed in Table 1. Myiasis occurred in 4 /39 (10%) of clinical cases diagnosed with cancer (basal cell carcinoma [wound myiasis/C. hominivorax, pituitary adenoma [wound myiasis/C. hominivorax], non-Hodgkin’s lymphoma [cavitary/no species identified], and vaginal verrucous carcinoma [cavitary/ no species identified). Other underlying health conditions included diabetes, alcoholism, malnutrition, elephantiasis, burns, otorrhea and rhinitis, schizophrenia, and senile dementia. Poor personal hygiene and low socioeconomic status was reported in some cases.

Treatment

Fourteen lesions in thirteen (33%) clinical cases received ivermectin (one topically, two intramuscularly, and the others orally from 200 to 400 μg/kg for 1 to 5 days) often followed by manual extraction. Ivermectin was observed to kill the larvae in all cases. Other treatments included surgical (16 or 41%) and manual extraction (18 or 46%), use of cigarette smoke and mechanical aspiration.

Discussion

Human myiasis is a recognized but under-reported health problem in Ecuador. Furuncular myiasis is known locally as ‘‘tupe”, “gusano de monte” or “gusano de bijao” while wound and cavity myiasis as “gusanera”. The indigenous Kichwa and Shuar tribes of the Amazon called it “kuruta wachak” and “munai”, respectively. In this review, we have presented data to show that this ectoparasitic infestation is endemic in all four geoclimatic regions of the country including the Galapagos Islands. Although myiasis is generally regarded as a tropical disease, our data show that it is also present in the temperate Andes, primarily among rural populations, although the incidence is greater in tropical regions of the Amazon and Pacific Coast regions. It is likely that incidence is underestimated substantially given that the population at risk has limited access to health facilities, particularly among indigenous groups in the Amazon region, and most patients with furuncular myiasis self-manage the condition using a variety of traditional remedies.

D. hominis was identified in almost half recorded clinical cases for whom identification was done, and occurred in tropical and subtropical regions of the Coast and Amazon. No cases caused by D. hominis were reported from the temperate Andes in accordance with the fact that D. hominis does not survive above an altitude of 1500m [13]. While C. hominivorax caused myiasis in both tropical and temperate regions, disease caused by this species was primarily identified among indigenous populations living in the Andean region where temperature ranges 8 to 18°C. C. hominivorax abounds in the foothills of the western Andes up to an altitude of 1,250m where it is the primary cause of bovine and ovine infestations [14], but appears also at higher altitudes during warmer months [13]. Previous studies indicate that D. hominis and C. hominivorax are the predominant agents of human myiasis in the New World [15]. Climatic changes due to global warming could modify the distribution of both flies resulting in future infestations in areas that are presently too cold to sustain these fly species.

Here we report for the first time an infestation with the facultative fly, Lucilia eximia (Wiedemann, 1819) (Diptera: Calliphoridae), in a prostrate elderly woman with a large necrotic leg wound from the mountainous Andes. The occurrence of Lucilia spp infestation has been reported infrequently with most cases from Australia where it is caused by L. cuprina [13]. Official data from the Ecuadorian MPH did not provide data on causative fly species. Reporting of myiasis within the MPH is not compulsory and the database carries records of diagnoses among outpatients but not of hospitalized inpatients, likely resulting in underreporting. Forty-one different species of dipterous flies have been reported to cause human myiasis worldwide [16], and we believe that it is likely that other species, in addition to the 5 already identified, will be implicated as causes of human myiasis in Ecuador if surveillance of myiasis and capacity for species identification can be improved. Physicians need to work more closely with biologists and entomologists to allow identification of new or invasive species across the diverse geoclimatic regions within the country.

Infestations of wounds and natural cavities with C. hominivorax resulted in severe disease, often associated with the presence of dozens of maggots in each lesion destroying healthy as well as necrotic tissue and resulting in disfigurement and blindness. Furthermore, C. hominivorax was implicated in a nosocomial case of myiasis, as reported previously [13], reflecting the capacity of the fly to infest open wounds or cavities in hospitals and nursing homes. Flies of C. hominivorax were also associated with infestations in the homeless and indigent. Since the fly is able to survive in more temperate regions of the Andes, particularly during warmer months, this puts the capital Quito at an altitude of 2,850 m and surrounding valleys within the area at risk for wound and/or cavitary infestations. C. hominivorax larvae can invade healthy tissues and burrow into adjacent organs, such as the brain, causing a rapidly fulminating and life-threatening illness [17].

Surgical removal and manual extraction are recommended for furuncular and for wound and some cavitary myiasis, respectively [17]. For wound and cavitary myiasis, tissue debridement and larval removal is often required [12]. In the present review, ivermectin was used in the treatment of fourteen clinical lesions (5 cavitary, 7 wound and 2 furuncular lesions). All individuals treated with ivermectin (200 to 400 μg/kg for one to five days) had their dead larvae (deflated, collapsed and retracted spines) expelled or removed manually within 24 to 48 h. Several studies have shown that ivermectin kills the larvae [17]. Care is required not to damage the larvae on extraction [2] and to ensure all larval debris (after ivermectin treatment) is removed to avoid the risk of secondary infections. Prior to the availability of ivermectin, surgical intervention was the treatment of choice while manual extraction was used for wound and cavitary myiasis. Widely used remedies for furuncular lesions among patients in rural areas are to ‘suffocate’ the larva using cigarette smoke or covering the pore with petroleum jelly, animal fat, nail polish, or topical application of animal vermifuges.

In conclusion, we report a significant annual incidence of myiasis throughout Ecuador, mainly in tropical and subtropical regions of the country but also in more temperate and mountainous regions. Furuncular myiasis caused by D. hominis was most common, including among travelers, while wound and cavitary myiasis, caused primarily by C. hominivorax was observed among the elderly and malnourished. Risk factors included poverty and contact with domestic animals, consistent with studies in neighboring countries [17]. From a travel health perspective, a knowledge of the geographical distribution of myiasis-causing species will improve clinical management. There is a need for greater awareness among and training of health professionals on myiasis, reporting of cases, identification of fly species, and appropriate treatment. Fly larvae found in lesions should be preserved for taxonomic identification.

Supporting information

S1 Data. Myiasis data extracted from Ecuadorian Ministry of Public Health National Automated Registry of Out-Patient Medical Consultations (Registro Diario Automatizado de Consultas y Atenciones Ambulatorias, RDACAA).

https://doi.org/10.1371/journal.pntd.0007858.s001

(XLSX)

Acknowledgments

We thank Rebeca Bravo for elaboration of the digitalized map.

References

  1. 1. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009;373: 1570–75. pmid:19410718
  2. 2. Francesconi F, Lupi O. Myiasis. Clin Microbiol Rev 2012;25:79. pmid:22232372
  3. 3. Villalobos G, Vega-Memije ME, Maravilla P, Martinez-Hernandez F. Myiasis caused by Dermatobia hominis: countries with increased risk for travelers going to neotropic areas. Int J Dermatol 2016;55:1060–8. pmid:27126902
  4. 4. Calvopina M, Armijos RX, Hashiguchi Y. Epidemiology of leishmaniasis in Ecuador: Current status of knowledge—A review. Mem Inst Oswaldo Cruz 2004;99:663–72. pmid:15654419
  5. 5. INEC. Instituto Nacional de Estadísticas y Censos. Resultados del Censo 2010 [Internet]. 2010. http://www.ecuadorencifras.gob.ec/resultados/
  6. 6. Sánchez-Sánchez R, Calderón-Arguedas Ó, Mora-Brenes N, Troyo A. Miasis nosocomiales en América Latina y el Caribe: ¿Una realidad ignorada? Rev Panam Salud Publica/Pan Am J Public Health. 2014;36:201–205.
  7. 7. Ortega-Munoz G, Luzuriaga-Neira N, Salazar-Silva R, Rodriguez-Hidalgo R. Oestrus ovis in Ecuador: importance in the Andean sheep farming. Vet World 2019;12:522–526. pmid:31190706
  8. 8. Fernandes LF, Pimenta FC, Fernandes FF. First Report of Human Myiasis in Goiás State, Brazil: Frequency of Different Types of Myiasis, Their Various Etiological Agents, and Associated Factors. J Parasitol 2009;95: 32–38. pmid:18576696
  9. 9. Chico M, Córdova M, Calvopiña M, Guderian R. Miasis Humana en el Ecuador. Rev Médica Vozandes 1994;3:101–106.
  10. 10. Singh A, Singh Z. Incidence of myiasis among humans—a review. Parasitol Res 2015;114:3183–99. pmid:26220558
  11. 11. Dominguez J, Cueva J, Cusco C, Rodríguez-Hidalgo R, Calvopiña M. Miasis orbital severa causada por Cochliomyia hominivorax en la región andina de Ecuador. Rev Mex Oftalmol 2015;90: 43–47.
  12. 12. Smith SM. Treating infestations of the human botfly, Dermatobia hominis. Lancet Infect Dis 2015;15:512. pmid:25932585
  13. 13. Latorre M, Ullate JV, Sanchez J, Calvo F, Cisterna R. A case of myiasis due to Dermatobia hominis. Eur J Clin Microbiol Infect Dis 1993;12:968–9. pmid:8187797
  14. 14. Westenfeld F. Cutaneous myiasis caused by Dermatobia hominis. Clinical Microbiology Newsletter 1993;15:39.
  15. 15. Chico M, Córdova M, Calvopiña M, Guderian R. Miasis Humana en el Ecuador. Rev Médica Vozandes. 1994;3: 101–106.
  16. 16. Hosokawa A, Nonaka S, Rosa G, Sud R, Gomez E, Hashiguchi Y. Case Reports of Cutaneous Myiasis due to Dermatobia hominis from an Area Endemic for Cutaneous Leishmaniasis in Ecuador. In: Un breve comentario sobre el patron cambiante de la leishmaniasis en el mundo. s.l, s.n, (Gomez EA,l Hashiguchi Y, eds) 2000;148–158.
  17. 17. Ortega J, Andrade M, Nacif J. Miasis intestinal causada por Callitroga americana. Rev Medicina 2000;6:38–40
  18. 18. Schwartz E, Gur H. Dermatobia hominis myiasis: an emerging disease among travelers to the Amazon basin of Bolivia. J Travel Med 2002;9:97–9. pmid:12044278
  19. 19. Cabrera F, Parra S, Palacios S. Miasis cutanea por Dematobia hominis. A proposito de 2 casos. Dermatologia 2002;11:32–35
  20. 20. Vaca-Aguirre P. Otomiasis. Rev Clinico-Quirurgica de Otorrinolaringologia 2003; 2:1–10
  21. 21. Guanga I. Cruz C. Miasis nasal. CAMBIOS 2006;5: 317–319
  22. 22. Andrade M, Gordillo V, Romero H. Miasis cutanea. Presentacion de un caso. Rev Sociedad Ecuatoriana Dermatologia 2007;1–4
  23. 23. Nagamori K, Katayama T, Kumagai M. A case of cutaneous myiasis due to Dermatobia hominis in Japan. Journal Infec Chemorther 2007;13:255–7.
  24. 24. Yerovi C, Garzón M, Tomalá C. Carcinoma verrucoso y miasis vaginal. A propósito de un caso. Medicina 2009;14:229–32.
  25. 25. Müller I, Vitagliano G. Miasis escrotal por larva de Dermatobia hominis. Reporte de un caso. Revista Argentina de Urología 2011;76:187–8.
  26. 26. Avendaño J. Blog de Intercambio de conocimientos sobre medicina ocupacional [Internet]2013. https://medicinaocupacionalecuador.wordpress.com/2012/03/20/a-proposito-de-un-caso-miasis-por-dermatobia-hominis-mosca-zumbadora/.
  27. 27. Angulo L, Rubio B, Zarco C, Vanaclocha F, Larrain H, Castellanos M, et al. Multiple furuncular myiasis caused by Dermatobia hominis. J Am Acad Dermatol 2014;70:AB104.
  28. 28. Cedeño J, Keil C, Ocampo J, Zapata M, Guerrero M. Miasis auricular por Cochliomyia hominovorax. Rev Fac Cien Med (Quito) 2014;39:87–90.
  29. 29. Pinos VH, Ortiz-Prado E, Bermeo C, Leon J, Armijos L, Almeida E. A unique case of facial burn superinfected with Dermatobia hominis larvae resulting in a bilateral enucleation of the eyes. Trop Doctor 2014;44:235–7.
  30. 30. Alemán Iñiguez JM, Reinoso S. Infestación maxilar por larvas Cochliomyia hominivorax. Primer reporte ecuatoriano de debridación en miasis gingivo maxilar. Rev Ecuat Med Cienc Biol 2014;35:21–9.
  31. 31. Domínguez Enríquez J, Cueva Rosillo J, Cusco Cuzco C, Rodríguez-Hidalgo R, Calvopiña M. Miasis orbital severa causada por Cochliomyia hominivorax en la región andina de Ecuador. Rev Mex Oftalmol 2015;90:43–7.
  32. 32. Coronel Yánez AP, Sacta Caguana BP, Crespo Coronel CM. Caso Clínico: Miasis Traumática. Rev Med HJCA 2016;8:82–5.
  33. 33. Piña-Tornés AA, Salvador-Fernández CL, Lindao-Camacho R, González-Longoria-Boada LB, Vintimilla-Burgos NP, Selles Almarales M. Massive cutaneous myiasis mimicking brain invasion. Case report and literature review. MÉDUIS 2016;29:145–53.
  34. 34. Dueñas Moreira O, Gámez Sánchez D, González Guerra QM. Miasis cutánea en un anciano de una comunidad rural ecuatoriana. MEDISAN 2017;21:590–4.
  35. 35. Ramírez Rivera JI, Mieles Figueroa JM, Penafiel Vicuña CI, Ramírez Rivera ME. Miasis en la colostomía de un lactante. Rev Chil Cirugía 2017;69:281–2.
  36. 36. Uslu U, Erdmann M, Schliep S, Sticherling M. Crusted Nodules on the Lower Left Arm in a Traveller Returning from South America: A Quiz. Furuncular myiasis. Acta Derm Venereol 2018;98:159–60. pmid:28952655